← Medical discoveries

Emmanuelle Charpentier and Jennifer Doudna, who developed CRISPR gene editing
Image: For Emmanuelle Charpentier portrait, credit Bianca Fioretti of Hallbauer & Fioretti. For Jennifer Doudna portrait, credit User:Duncan.Hull and The Royal Soci… · CC BY-SA 4.0, via Wikimedia Commons

Public health and research

The first CRISPR medicine

The UK approved Casgevy, a treatment that edits a patient's own blood stem cells with CRISPR to treat sickle cell disease and beta-thalassaemia. It followed the gene-editing work of Emmanuelle Charpentier and Jennifer Doudna.

Why it matters

It is the first approved medicine to use gene editing, aimed at diseases that mostly affect people in Africa and India.

For patients

Sickle cell patients faced lifelong pain crises; in trials most were free of them after one treatment.

People: Emmanuelle Charpentier, Jennifer Doudna

Builds on: The human genome read

Sources